Literature DB >> 21975953

Protein glycosylation and its impact on biotechnology.

Markus Berger, Matthias Kaup, Veronique Blanchard.   

Abstract

Glycosylation is a post-translational modification that is of paramount importance in the production of recombinant pharmaceuticals as most recombinantly produced therapeutics are N- and/or O-glycosylated. Being a cell-system-dependent process, it also varies with expression systems and growth conditions, which result in glycan microheterogeneity and macroheterogeneity. Glycans have an effect on drug stability, serum half-life, and immunogenicity; it is therefore important to analyze and optimize the glycan decoration of pharmaceuticals. This review summarizes the aspects of protein glycosylation that are of interest to biotechnologists, namely, biosynthesis and biological relevance, as well as the tools to optimize and to analyze protein glycosylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21975953     DOI: 10.1007/10_2011_101

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  7 in total

Review 1.  Differentiating biosimilarity and comparability in biotherapeutics.

Authors:  Valderilio Azevedo; Brian Hassett; João Eurico Fonseca; Tatsuya Atsumi; Javier Coindreau; Ira Jacobs; Ehab Mahgoub; Julie O'Brien; Ena Singh; Steven Vicik; Brian Fitzpatrick
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

2.  Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.

Authors:  Stefan Michelfelder; Juliana Parsons; Lennard L Bohlender; Sebastian N W Hoernstein; Holger Niederkrüger; Andreas Busch; Nicola Krieghoff; Jonas Koch; Benjamin Fode; Andreas Schaaf; Thomas Frischmuth; Martin Pohl; Peter F Zipfel; Ralf Reski; Eva L Decker; Karsten Häffner
Journal:  J Am Soc Nephrol       Date:  2016-12-08       Impact factor: 10.121

3.  High-quality production of human α-2,6-sialyltransferase in Pichia pastoris requires control over N-terminal truncations by host-inherent protease activities.

Authors:  Doris Ribitsch; Sabine Zitzenbacher; Peter Augustin; Katharina Schmölzer; Tibor Czabany; Christiane Luley-Goedl; Marco Thomann; Christine Jung; Harald Sobek; Rainer Müller; Bernd Nidetzky; Helmut Schwab
Journal:  Microb Cell Fact       Date:  2014-09-11       Impact factor: 5.328

4.  The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.

Authors:  Inmaculada Cuchillo-Ibañez; Trinidad Mata-Balaguer; Valeria Balmaceda; Juan José Arranz; Johannes Nimpf; Javier Sáez-Valero
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

Review 5.  Biosimilars: Key regulatory considerations and similarity assessment tools.

Authors:  Carol F Kirchhoff; Xiao-Zhuo Michelle Wang; Hugh D Conlon; Scott Anderson; Anne M Ryan; Arindam Bose
Journal:  Biotechnol Bioeng       Date:  2017-09-19       Impact factor: 4.530

6.  Site-Specific Glycan Microheterogeneity Evaluation of Aflibercept Fusion Protein by Glycopeptide-Based LC-MSMS Mapping.

Authors:  Ju Yeon Lee; Jin-Woong Choi; Seoyoung Hwang; Sung Ho Hahm; Yeong Hee Ahn
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

7.  Dissecting N-Glycosylation Dynamics in Chinese Hamster Ovary Cells Fed-batch Cultures using Time Course Omics Analyses.

Authors:  Madhuresh Sumit; Sepideh Dolatshahi; An-Hsiang Adam Chu; Kaffa Cote; John J Scarcelli; Jeffrey K Marshall; Richard J Cornell; Ron Weiss; Douglas A Lauffenburger; Bhanu Chandra Mulukutla; Bruno Figueroa
Journal:  iScience       Date:  2019-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.